After years of anticipation, Botox’s biggest competitor has finally been approved by the FDA for cosmetic use in the U.S. Originally expected to be called Reloxin, abobotulinumtoxinA will available under […]
and improve its content and advertising. Please review our
for more about how we use this data. By continuing to use this site,
you agree to these policies.